Pericardial fat, insulin resistance, and left ventricular structure and function in morbid obesity

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 4, 2014, Pages 440-446

  Pucci, G ^a,b   Battista, F ^a,b   de Vuono, S ^a   Boni, M ^c   Scavizzi, M ^a   Ricci, M A ^a   Lupattelli, G ^a   Schillaci, G ^a,b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b University Hospital of Terni   (Italy)

^c Foligno Hospital   (Italy)

Author keywords

Echocardiography; Epicardial fat; Insulin resistance; Left ventricular hypertrophy; Mid wall fractional shortening; Obesity; Pericardial fat

Indexed keywords

FAT; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIAC ECTOPIC FAT; DISEASE ASSOCIATION; EPICARDIUM; FEMALE; HEART CONTRACTION; HEART DISEASE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PERICARDIUM; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ADIPOSE TISSUE; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; DIAGNOSIS; ECHOGRAPHY; ETIOLOGY; HEART LEFT VENTRICLE FUNCTION; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; OBESITY; OBESITY, MORBID; PATHOPHYSIOLOGY; RISK FACTOR; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ADIPOSITY; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY, MORBID; PERICARDIUM; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; WAIST CIRCUMFERENCE;

EID: 84897085790     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.09.016     Document Type: Article

References (38)

1. Health, United States 2010, National Center for Health Statistics, Available from:, [accessed 26.02.13]. http://www.cdc.gov/nchs/hus.htm.
2. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health 2007, 121:492-496.
3. Livingston E.H., Ko C.Y. Effect of diabetes and hypertension on obesity-related mortality. Surgery 2005, 137:16-25.
4. Pischon T., Boeing H., Hoffmann K., Bergmann M., Schulze M.B., Overvad K., et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008, 359:2105-2120.
5. Coutinho T., Goel K., Corrêa de Sá D., Kragelund C., Kanaya A.M., Zeller M., et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol 2011, 57:1877-1886.
6. Britton K.A., Fox C.S. Ectopic fat depots and cardiovascular disease. Circulation 2011, 124:e837-e841.
7. Preis S.R., Massaro J.M., Robins S.J., Hoffmann U., Vasan R.S., Irlbeck T., et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring) 2010, 18:2191-2198.
8. Gaborit B., Kober F., Jacquier A., Moro P.J., Cuisset T., Boullu S., et al. Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat. Int J Obes (Lond) 2012, 36:422-430.
9. Fox C.S., Gona P., Hoffmann U., Porter S.A., Salton C.J., Massaro J.M., et al. Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation 2009, 119:1586-1591.
10. Sade L.E., Eroglu S., Bozbaş H., Ozbiçer S., Hayran M., Haberal A., et al. Relation between epicardial fat thickness and coronary flow reserve in women with chest pain and angiographically normal coronary arteries. Atherosclerosis 2009, 204:580-585.
11. Ding J., Hsu F.C., Harris T.B., Liu Y., Kritchevsky S.B., Szklo M., et al. The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2009, 90:499-504.
12. Iacobellis G., Assael F., Ribaudo M.C., Zappaterreno A., Alessi G., Di Mario U., et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003, 11:304-310.
13. Iacobellis G., Ribaudo M.C., Zappaterreno A., Iannucci C.V., Leonetti F. Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol 2004, 94:1084-1087.
14. Iacobellis G., Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab 2005, 90:6300-6302.
15. Iacobellis G., Ribaudo M.C., Assael F., Vecci E., Tiberti C., Zappaterreno A., et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003, 88:5163-5168.
16. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus development conference statement. Am J Clin Nutr 1992, 55(Suppl. 2):615S-619S.
17. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
18. Ascaso J.F., Pardo S., Real J.T., Lorente R.I., Priego A., Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003, 26:3320-3325.
19. International Expert Committee Report on the role of the HbA1c assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334.
20. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58:1072-1083. The Committee on M-Mode Standardization of the American Society of Echocardiography.
21. de Simone G., Devereux R.B., Daniels S.R., Koren M.J., Meyer R.A., Laragh J.H. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995, 25:1056-1062.
22. de Simone G., Devereux R.B., Kimball T.R., Mureddu G.F., Roman M.J., Contaldo F., et al. Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension 1998, 31:1077-1082.
23. Teichholz L.E., Kreulen T., Herman M.V., Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976, 37:7-11.
24. Shimizu G., Hirota Y., Kita Y., Kawamura K., Saito T., Gaasch W.H. Left ventricular midwall mechanics in systemic arterial hypertension: myocardial function is depressed in pressure-overload hypertrophy. Circulation 1991, 83:1676-1684.
25. Schillaci G., Verdecchia P., Reboldi G., Pede S., Porcellati C. Subclinical left ventricular dysfunction in systemic hypertension and the role of 24-hour blood pressure. Am J Cardiol 2000, 86:509-513.
26. Schejbal V. Epicardial fatty tissue of the right ventricle-morphology, morphometry and functional significance. Pneumologie 1989, 43:490-499.
27. Avelar E., Cloward T.V., Walker J.M., Farney R.J., Strong M., Pendleton R.C., et al. Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, and body mass. Hypertension 2007, 49:34-39.
28. Messerli F.H., Sundgaard-Riise K., Reisin E.D., Dreslinski G.R., Ventura H.O., Oigman W., et al. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med 1983, 99:757-761.
29. Malavazos A.E., Corsi M.M., Ermetici F., Coman C., Sardanelli F., Rossi A., et al. Proinflammatory cytokines and cardiac abnormalities in uncomplicated obesity: relationship with abdominal fat deposition. Nutr Metab Cardiovasc Dis 2007, 17:294-302.
30. Iozzo P. Myocardial, perivascular, and epicardial fat. Diabetes Care 2011, 34(Suppl. 2):S371-S379.
31. de Simone G., Verdecchia P., Pede S., Gorini M., Maggioni A.P. Prognosis of inappropriate left ventricular mass in hypertension: the MAVI Study. Hypertension 2002, 40:470-476.
32. Chinali M., de Simone G., Roman M.J., Lee E.T., Best L.G., Howard B.V., et al. Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol 2006, 47:2267-2273.
33. de Simone G., Devereux R.B., Mureddu G.F., Roman M.J., Ganau A., Alderman M.H., et al. Influence of obesity on left ventricular midwall mechanics in arterial hypertension. Hypertension 1996, 28:276-283.
34. Owan T., Avelar E., Morley K., Jiji R., Hall N., Krezowski J., et al. Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the Utah obesity study. J Am Coll Cardiol 2011, 57:732-739.
35. Sicari R., Sironi A.M., Petz R., Frassi F., Chubuchny V., De Marchi D., et al. Pericardial rather than epicardial fat is a cardiometabolic risk marker: an MRI vs echo study. J Am Soc Echocardiogr 2011, 24:1156-1162.
36. Verdecchia P., Reboldi G., Schillaci G., Borgioni C., Ciucci A., Telera M.P., et al. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999, 100:1802-1807.
37. de Simone G., Devereux R.B., Palmieri V., Bella J.N., Oberman A., Kitzman D.W., et al. Influence of fat-free mass on detection of appropriateness of left ventricular mass: the HyperGEN Study. J Hypertens 2003, 21:1747-1752. HyperGEN Study.
38. Celentano A., Palmieri V., Esposito N.D., Pietropaolo I., Crivaro M., Mureddu G.F., et al. Inappropriate left ventricular mass in normotensive and hypertensive patients. Am J Cardiol 2001, 87:361-363.